INS and obesity due to melanocortin 4 receptor deficiency: In the recent years, the strong evidences were obtained that the important target for MF is the hypothalamus, and its effects on the hypothalamic signaling makes an important contribution to MF-induced improvement of the metabolic processes and the peripheral insulin and leptin sensitivity in obesity and other metabolic disorders [23].